CF PharmTech, Inc. (HKG:2652)
Hong Kong · Delayed Price · Currency is HKD 34.14
-0.86 (-2.46%)
At close: Dec 30, 2025
CF PharmTech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 27.75 | 21.09 | 31.73 | -49.4 | -131.73 | -405.13 |
Depreciation & Amortization | 61.27 | 58.85 | 52.96 | 38.2 | 27.9 | 14.83 |
Other Amortization | 1.68 | 1.34 | 1.2 | 0.69 | 1.9 | 1.13 |
Loss (Gain) From Sale of Assets | 0.1 | 0.63 | 0.39 | 0.81 | 0.01 | -0.01 |
Asset Writedown & Restructuring Costs | - | - | - | - | -0.3 | -3.04 |
Loss (Gain) From Sale of Investments | -5.89 | -7.05 | -8.68 | -7.99 | -13.35 | -4.22 |
Loss (Gain) on Equity Investments | 0.06 | 0.07 | 0.1 | - | - | - |
Stock-Based Compensation | 10.99 | 7.82 | 16.68 | 15.92 | 14.24 | 270.99 |
Provision & Write-off of Bad Debts | - | - | - | - | 0.06 | -0 |
Other Operating Activities | 0.97 | 1.82 | -8.22 | -27.41 | -4.86 | -5.97 |
Change in Accounts Receivable | -45.43 | -25.55 | 6.39 | -8.26 | -3.38 | -20.36 |
Change in Inventory | -1.48 | -12.97 | -10.66 | -8.51 | -15.99 | -1.65 |
Change in Accounts Payable | 3.85 | 7.43 | 0.18 | -5.97 | 31.27 | 37.74 |
Change in Unearned Revenue | -3.52 | -3.52 | 18.59 | -0.42 | - | - |
Change in Other Net Operating Assets | 50.18 | 46.5 | 15.64 | 97.81 | - | - |
Operating Cash Flow | 100.53 | 96.46 | 116.29 | 45.47 | -156.69 | -115.69 |
Operating Cash Flow Growth | - | -17.05% | 155.77% | - | - | - |
Capital Expenditures | -162.2 | -167.66 | -114.64 | -91.19 | -91.25 | -171.36 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.02 |
Sale (Purchase) of Intangibles | -30.78 | -32.99 | -23.7 | -15.74 | - | - |
Investment in Securities | 60 | 65 | 14.76 | -34 | 375.92 | -566.85 |
Other Investing Activities | 24.8 | 22.21 | -4.08 | -10.5 | 16.4 | 4.25 |
Investing Cash Flow | -108.18 | -113.44 | -127.65 | -151.42 | 301.06 | -733.94 |
Long-Term Debt Issued | - | 54.8 | 20 | - | - | - |
Long-Term Debt Repaid | - | -5.78 | -3.55 | -4.01 | - | - |
Net Debt Issued (Repaid) | 19.7 | 49.02 | 16.45 | -4.01 | - | - |
Issuance of Common Stock | - | - | - | - | - | 883.73 |
Other Financing Activities | -23.78 | -20.33 | -8.58 | -1.4 | -4.5 | -13.92 |
Financing Cash Flow | -4.08 | 28.69 | 7.88 | -5.41 | -4.5 | 869.81 |
Foreign Exchange Rate Adjustments | -0.51 | -0.39 | -0.74 | 2.92 | -1.75 | -5.39 |
Net Cash Flow | -12.24 | 11.33 | -4.23 | -108.45 | 138.11 | 14.78 |
Free Cash Flow | -61.67 | -71.2 | 1.65 | -45.72 | -247.95 | -287.05 |
Free Cash Flow Margin | -10.21% | -11.72% | 0.30% | -13.10% | -590.55% | -5907.83% |
Free Cash Flow Per Share | -0.17 | -0.19 | 0.00 | -0.12 | - | - |
Cash Interest Paid | 1.87 | 1.52 | - | - | - | - |
Cash Income Tax Paid | - | - | - | - | -15.79 | -3.07 |
Levered Free Cash Flow | - | -95.58 | 45.97 | -135.42 | -207.07 | - |
Unlevered Free Cash Flow | - | -94.47 | 46.07 | -135.32 | -206.98 | - |
Change in Working Capital | 3.61 | 11.89 | 30.14 | 74.65 | -50.57 | 15.73 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.